Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
- 31 January 2006
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 21 (1), 237-245
- https://doi.org/10.1016/j.nbd.2005.07.008
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation
- National Institute on Drug Abuse
- United States-Israel Binational Science Foundation
This publication has 51 references indexed in Scilit:
- Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in miceBrain Research Bulletin, 2005
- Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease BrainsJournal of Neuroscience, 2003
- Tetrahydrocannabinol and endocannabinoids in feeding and appetitePharmacology & Therapeutics, 2002
- Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activationInternational Immunopharmacology, 2001
- Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosisNature Medicine, 2001
- Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systemsCurrent Opinion in Neurology, 2000
- An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activityEuropean Journal of Pharmacology, 1998
- Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptorsPsychopharmacology, 1997
- Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathyHepatology, 1997
- Elevated Brain Concentrations of 1,4-Benzodiazepines in Fulminant Hepatic FailureNew England Journal of Medicine, 1991